Back
Brainstorm Cell Therapeutics Vs. Carvana Industry Stock Comparison
Sell
7
BCLI
Brainstorm Cell Therapeutics
Last Price:
1.87
Seasonality Move:
2.27%
Buy
77
CVNA
Carvana
Last Price:
247.02
Seasonality Move:
4.25%
Sell
7
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Is Brainstorm Cell Therapeutics a Buy, Sell or Hold?
- The current Brainstorm Cell Therapeutics [BCLI] share price is $1.87. The Score for BCLI is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
- BCLI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
77
Carvana (CVNA)
is a Buy
Is Carvana a Buy, Sell or Hold?
- The current Carvana [CVNA] share price is $247.31. The Score for CVNA is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- CVNA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BCLI Stock Price Chart
What is Brainstorm Cell Therapeutics's stock price today?
-
The Brainstorm Cell Therapeutics share price today is $1.87
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing slight selling pressure.
CVNA Stock Price Chart
BCLI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.39 | Sell |
| Relative Strength Index (14 RSI): | 30.53 | Sell |
| Chaikin Money Flow: | -6697 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.82 - 2.88) | Sell |
| Bollinger Bands (100): | (2.96 - 5.76) | Sell |
CVNA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 13.13 | Buy |
| Relative Strength Index (14 RSI): | 90.1 | Buy |
| Chaikin Money Flow: | 998789 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (177.27 - 207.77) | Buy |
| Bollinger Bands (100): | (122.71 - 180.55) | Buy |
BCLI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.97 | Sell |
| 20-day SMA: | 2.11 | Sell |
| 50-day SMA: | 3.3 | Sell |
| 200-day SMA: | 5.56 | Sell |
| 8-day EMA: | 1.99 | Sell |
| 20-day EMA: | 2.27 | Sell |
| 50-day EMA: | 3.11 | Sell |
| 200-day EMA: | 6.38 | Sell |
CVNA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 208.23 | Buy |
| 20-day SMA: | 196.99 | Buy |
| 50-day SMA: | 172.96 | Buy |
| 200-day SMA: | 116.09 | Buy |
| 8-day EMA: | 212.17 | Buy |
| 20-day EMA: | 198.29 | Buy |
| 50-day EMA: | 178.03 | Buy |
| 200-day EMA: | 125.85 | Buy |
Brainstorm Cell Therapeutics Earnings Growth & BCLI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.79 per share, and an increase next year of $0.67 per share.
Carvana Earnings Growth & CVNA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.01 per share, and a decrease next year of $0.43 per share.
Brainstorm Cell Therapeutics Technical Analysis
| Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Carvana Technical Analysis
| Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||